Qualitative and quantitative cytomorphological features of primary anaplastic lymphoma kinase-positive lung cancer.


Journal

Cytopathology : official journal of the British Society for Clinical Cytology
ISSN: 1365-2303
Titre abrégé: Cytopathology
Pays: England
ID NLM: 9010345

Informations de publication

Date de publication:
05 2019
Historique:
received: 27 08 2018
accepted: 20 11 2018
pubmed: 7 12 2018
medline: 21 5 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Anaplastic lymphoma kinase (ALK) positive (+) lung cancers are predictive for response to crizotinib and alectinib. There are many cases of lung cancer in which surgery cannot be performed, and such cases require diagnosis by cytological specimen or biopsy. Estimating ALK (+) lung cancer from cytomorphology would allow molecular testing to proceed without the waste of a small amount of specimen. The purpose of this study was to assess whether qualitative and quantitative cytomorphological features are sufficient for distinguishing primary ALK (+) from ALK (-) lung cancer. We examined eight qualitative cytomorphological parameters and three quantitative nuclear morphometric parameters in 17 cases of primary ALK (+) lung cancer, diagnosed by fluorescence in situ hybridisation (FISH) using histological specimens, and in 41 cases of ALK (-) lung cancer. Quantitative nuclear morphometric parameters were analysed by a computer-assisted image analysis system. In ALK (+) lung cancer, three qualitative parameters (signet ring cells, nuclear grooves and single type nucleoli) and two quantitative parameters (large nuclear area and irregular nuclear shape) were observed in significantly higher proportions. However, in ALK (-) lung cancer, one qualitative parameter (unclear and multiple type nucleoli) was seen significantly more often. These results show that the cytomorphological features of signet ring cells, nuclear grooves and nucleoli shape can help to triage a small amount of cytological and biopsy specimens for appropriate molecular testing of primary ALK (+) lung cancer.

Identifiants

pubmed: 30506595
doi: 10.1111/cyt.12667
doi:

Substances chimiques

ALK protein, human EC 2.7.10.1
Anaplastic Lymphoma Kinase EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-300

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Ryuko Tsukamoto (R)

Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.

Hiroyuki Ohsaki (H)

Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.

Sho Hosokawa (S)

Department of Medical Technology, Ehime Prefectural University of Health Sciences, Ehime, Japan.

Yasunori Tokuhara (Y)

Department of Medical Technology, Ehime Prefectural University of Health Sciences, Ehime, Japan.

Shingo Kamoshida (S)

Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.

Toshiko Sakuma (T)

Department of Pathology, Hyogo Cancer Center, Hyogo, Japan.

Tomoo Itoh (T)

Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.

Chiho Ohbayashi (C)

Department of Diagnostic Pathology, Nara Medical University, Nara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH